Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Drug Updates
,
FDA Approvals
,
Prostate Cancer
Xtandi Now Approved for Metastatic Castration-Sensitive Prostate Cancer
Read More
Drug Updates
,
FDA Approvals
Keytruda Indicated for BCG-Unresponsive High-Risk, Non–Muscle Invasive Bladder Cancer
Read More
Drug Updates
,
FDA Approvals
Ayvakit First Targeted Therapy Approved for Gastrointestinal Stromal Tumors with PDGFRA Mutation
Read More
Breast Cancer
,
Drug Updates
,
FDA Approvals
Enhertu, a Dual-Targeted Therapy, Approved for Metastatic HER2-Positive Breast Cancer
Read More
Drug Updates
,
FDA Approvals
Padcev, a Novel Targeted Therapy, FDA Approved for Advanced or Metastatic Urothelial Cancer
Read More
Drug Updates
,
FDA Approvals
Tazverik First FDA-Approved Drug for Advanced Epithelioid Sarcoma Ineligible for Resection
Read More
Drug Updates
,
FDA Approvals
,
Pancreatic Cancer
Lynparza Indicated for Maintenance Treatment of Metastatic Pancreatic Cancer with BRCA Mutation
Read More
Drug Updates
,
FDA Approvals
,
In the News
,
Select Drug Profiles
November 11, 2019 — Oncology News & Updates
Read More
Drug Updates
,
FDA Approvals
,
Payers' Guide
FDA Approvals of Novel Brand-Name Prescription Drugs in 2018
Read More
FDA Approvals
,
FDA Approvals
,
Drug Updates
,
Payers' Guide
FDA Approvals of Brand-Name Prescription Drugs in 2016
Read More
1
2
3
4
Page 1 of 8
Results 1 - 10 of 80